Eli Lilly Market Cap 2006-2019 | LLY

Eli Lilly market cap history and chart from 2006 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of diluted shares outstanding. Eli Lilly market cap as of May 24, 2019 is $113.38B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $113.383B $24.556B
Eli Lilly and Company is a global healthcare leader that unites caring with discovery to make life better for people around the world. They were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and they remain true to that mission in all their work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $372.521B 16.89
Pfizer (PFE) United States $249.723B 13.62
Merck (MRK) United States $218.850B 18.00
Novartis AG (NVS) Switzerland $202.171B 17.47
Novo Nordisk (NVO) Denmark $118.731B 19.75
AbbVie (ABBV) United States $118.355B 9.79
Sanofi (SNY) France $105.545B 13.01
GlaxoSmithKline (GSK) United Kingdom $99.670B 12.64
AstraZeneca (AZN) United Kingdom $98.834B 11.38
Bristol-Myers Squibb (BMY) United States $76.567B 11.31